RPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Repros Therapeutics Inc's account receivable for the three months ended in Sep. 2016 was $0.00 Mil. Repros Therapeutics Inc's revenue for the three months ended in Sep. 2016 was $0.01 Mil. Hence, Repros Therapeutics Inc's days sales outstanding for the three months ended in Sep. 2016 was 0.00.
Repros Therapeutics Inc's days sales outstanding stayed the same from Sep. 2015 (0.00) to Sep. 2016 (0.00).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Repros Therapeutics Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2015 is calculated as
Repros Therapeutics Inc's Days Sales Outstanding for the quarter that ended in Sep. 2016 is calculated as:
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Repros Therapeutics Inc Annual Data
Repros Therapeutics Inc Quarterly Data